NUTX - NASDAQ
Nutex Health, Inc.
$132.83
+6.2%Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
At a Glance
Live Snapshotnutx
Total Liabilities and Equity
Last Annual Value
918.52M
3-Year CAGR
29%
5-Year CAGR
24%
10-Year CAGR
61%
Nutex Health, Inc. Competitors Analysis of Total Liabilities and Equity
| Company | Total Liabilities and Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Nutex Health, Inc. NASDAQ:NUTX | 918.52M | 32.1% | 18.4% | 111.6% | |
 Ginkgo Bioworks Holdings, Inc. NYSE:DNA | 1.12B | -12.4% | -11.6% | N/A | |
 HealthStream, Inc. NASDAQ:HSTM | 520.37M | 1.3% | 1.3% | 2.8% | |
 Pacific Biosciences of California, Inc. NASDAQ:PACB | 784.08M | -23.4% | -17.1% | 19.0% | |
 Day One Biopharmaceuticals, Inc. NASDAQ:DAWN | 507.83M | 10.5% | 11.9% | N/A | |
 Replimune Group, Inc. NASDAQ:REPL | 551.33M | -5.2% | 0.3% | N/A | |
 Evolent Health, Inc. NYSE:EVH | 1.90B | -10.8% | 6.0% | 4.7% | |
 Butterfly Network, Inc. NYSE:BFLY | 296.53M | -0.9% | -12.3% | N/A | |
 Myriad Genetics, Inc. NASDAQ:MYGN | 706.60M | -14.9% | -11.8% | -5.3% | |
 AMN Healthcare Services, Inc. NYSE:AMN | 2.09B | -10.5% | -7.7% | 5.8% | |
 CareDx, Inc NASDAQ:CDNA | 413.23M | -4.0% | -6.1% | 18.3% |
Nutex Health, Inc. Fair Value Envelope
Related Guides
Continue your NUTX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.